This inconsistence also occurred to miR-130a, which was shown to not only inhibit tumor suppressor RUNX3 in hepatocellular carcinoma[38] but also suppress proto-oncogene MET in lung cancer. Here, RUNX3 is linked to hepatocellular carcinoma.